Pharmaceutical Filtration Market worth $26.2 billion by 2028

As per the recently published report by MarketsandMarket?, The report "Pharmaceutical Filtration Market by Product (Membrane, Depth filter), System (Single use, Reusable), Technique (Microfiltration, Nanofiltration), Application (API, Vaccine, Antibody), Scale of Operation (Manufacturing, Pilot, R&D) - Global Forecast to 2028", is projected to reach USD 26.2 billion by 2028 from USD 13.5 billion in 2023, at a CAGR of 14.2% during the forecast period of 2023 to 2028.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=209343847 ?

Browse

• 514? ? ?Market Data Tables
• 49? ? ? ?Figures
• 454? ? ?Pages and in-depth TOC on?" Pharmaceutical Filtration Market - Global Forecast to 2028”

Some of the prominent key players are:

• Merck KGaA (Germany),
• Danaher Corporation (US),
• Sartorius AG (Germany),
• 3M (US),
• Thermo Fisher Scientific Inc. (US), and many more......

Mergers & acquisitions, investments & expansions, partnerships & collaborations, and new product developments are some of the major strategies adopted by these key players to enhance their positions in the Pharmaceutical Filtration Market.

• Based on products, the pharmaceutical filtration market is segmented into filters, systems, and other products. Filters segment accounted for the largest share of the pharmaceutical market, membrane filters are the key revenue contributors to this segment. Membrane filters are microporous plastic films with specific pore size ratings.
• Based on technique, the pharmaceutical filtration market is segmented into microfiltration, ultrafiltration, nanofiltration, and other techniques. The other techniques segment includes reverse osmosis and ion exchange. The nanofiltration techniques accounted for the smallest market share of this market in 2022,
• Based on the region, the Pharmaceutical filtration market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific is estimated to be the fastest-growing segment of the market owing to the rapid technology development in nanofiber technologies, expanding manufacturing of generics, growing government budget for R&D, and growing biotechnology industries.

Growth in the global market can be attributed to factors such as the expanding biopharmaceutical industry, increased R&D spending by the government and top companies in pharmaceutical and biotechnology industries, rapidly growing adoption of single-use technologies, multiple product launches by leading market players, scrutiny for purity requirements by end users, and growing advances in nanofiber technology. However, membrane fouling and huge capital investment required to set up new production facilities are expected to adversely impact market growth.